NL155827B - Werkwijze voor de bereiding van antibacterieel werkzame benzylpyrimidinen, alsmede voor de bereiding van antibacterieel werkzame preparaten, die deze verbindingen bevatten, en de gevormde preparaten. - Google Patents

Werkwijze voor de bereiding van antibacterieel werkzame benzylpyrimidinen, alsmede voor de bereiding van antibacterieel werkzame preparaten, die deze verbindingen bevatten, en de gevormde preparaten.

Info

Publication number
NL155827B
NL155827B NL7411685.A NL7411685A NL155827B NL 155827 B NL155827 B NL 155827B NL 7411685 A NL7411685 A NL 7411685A NL 155827 B NL155827 B NL 155827B
Authority
NL
Netherlands
Prior art keywords
preparation
active
preparations
antibacterally
benzylpyrimidines
Prior art date
Application number
NL7411685.A
Other languages
English (en)
Dutch (nl)
Other versions
NL7411685A (nl
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NL7411685A publication Critical patent/NL7411685A/xx
Publication of NL155827B publication Critical patent/NL155827B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C07D207/327Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • C07D239/49Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NL7411685.A 1973-09-12 1974-09-03 Werkwijze voor de bereiding van antibacterieel werkzame benzylpyrimidinen, alsmede voor de bereiding van antibacterieel werkzame preparaten, die deze verbindingen bevatten, en de gevormde preparaten. NL155827B (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1305773A CH591456A5 (es) 1973-09-12 1973-09-12

Publications (2)

Publication Number Publication Date
NL7411685A NL7411685A (nl) 1975-03-14
NL155827B true NL155827B (nl) 1978-02-15

Family

ID=4388903

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7411685.A NL155827B (nl) 1973-09-12 1974-09-03 Werkwijze voor de bereiding van antibacterieel werkzame benzylpyrimidinen, alsmede voor de bereiding van antibacterieel werkzame preparaten, die deze verbindingen bevatten, en de gevormde preparaten.

Country Status (28)

Country Link
JP (1) JPS6042238B2 (es)
AR (2) AR207764A1 (es)
AT (1) AT338797B (es)
BE (1) BE819773A (es)
BR (1) BR7407614D0 (es)
CA (1) CA1037476A (es)
CH (1) CH591456A5 (es)
CU (1) CU34115A (es)
DD (2) DD122785A5 (es)
DE (1) DE2443682C2 (es)
DK (1) DK135683B (es)
ES (7) ES429949A1 (es)
FI (1) FI58638C (es)
FR (1) FR2242984B1 (es)
GB (3) GB1484483A (es)
HK (1) HK181A (es)
HU (1) HU170427B (es)
IE (1) IE40523B1 (es)
IL (1) IL45510A (es)
LU (1) LU70878A1 (es)
NL (1) NL155827B (es)
NO (1) NO140858C (es)
PH (1) PH10643A (es)
PL (2) PL99159B1 (es)
SE (1) SE419443B (es)
SU (3) SU577987A3 (es)
YU (3) YU217874A (es)
ZA (1) ZA745317B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4515948A (en) * 1973-09-12 1985-05-07 Hoffmann-La Roche Inc. 2,4-Diamino-5-(4-amino and 4-dimethylamino-3,5-dimethoxy benzyl)pyrimidines
EP0001633A1 (en) * 1977-10-18 1979-05-02 The Wellcome Foundation Limited Processes for preparing tri-heterocyclic substituted methanes and their conversion into further intermediates useful in the preparation of pharmacologically active compounds
CH639273A5 (de) * 1978-09-12 1983-11-15 Hoffmann La Roche Diuretische mittel.
CH664959A5 (de) * 1981-11-09 1988-04-15 Wellcome Found Verfahren zur herstellung von substituierten 2,4-diamino-5-benzylpyrimidinen.
DE3250132C2 (de) * 1981-11-09 1997-01-16 Mallinckrodt Veterinary Inc Verfahren zur Herstellung von 2,4-Diamino-5-benzyl-pyrimidinen und neue Zwischenprodukte des Verfahrens
GB2180836A (en) * 1985-09-27 1987-04-08 William James Stephen Barker Sunscreen
JPH0431685Y2 (es) * 1987-06-01 1992-07-30
US4900859A (en) * 1987-12-03 1990-02-13 Hoffman-La Roche Inc. Process for 4-dimethylamino-3,5-dimethoxybenzaldehyde
CA1300166C (en) * 1987-12-03 1992-05-05 Alfredo Guerrato Process for the preparation of a benzoic acid ester

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1103931B (de) * 1957-02-21 1961-04-06 Wellcome Found Verfahren zur Herstellung von 2, 4-Diamino-5-benzylpyrimidinderivaten
US3485840A (en) * 1964-11-12 1969-12-23 Hoffmann La Roche 2,4-diamino - 5 - (2',4',5'-substituted benzyl) pyrimidines,intermediates and processes

Also Published As

Publication number Publication date
IE40523B1 (en) 1979-06-20
YU217874A (en) 1982-06-18
DK468374A (es) 1975-05-12
FI58638C (fi) 1981-03-10
ZA745317B (en) 1975-11-26
FI256174A (es) 1975-03-13
YU37153B (en) 1984-08-31
SU571189A3 (ru) 1977-08-30
NO140858C (no) 1979-11-28
IL45510A0 (en) 1974-11-29
YU301580A (en) 1983-04-27
NO743271L (es) 1975-04-07
YU37154B (en) 1984-08-31
AR211387Q (es) 1977-12-15
JPS6042238B2 (ja) 1985-09-20
YU301680A (en) 1983-04-27
AR207764A1 (es) 1976-10-29
CA1037476A (en) 1978-08-29
AU7263174A (en) 1976-02-26
CU34115A (es) 1983-10-04
HK181A (en) 1981-01-16
BR7407614D0 (pt) 1975-07-08
SE419443B (sv) 1981-08-03
ATA735174A (de) 1977-01-15
DE2443682A1 (de) 1975-03-20
DD116824A5 (es) 1975-12-12
CH591456A5 (es) 1977-09-15
FR2242984A1 (es) 1975-04-04
HU170427B (es) 1977-06-28
JPS5053385A (es) 1975-05-12
PL99159B1 (pl) 1978-06-30
DK135683B (da) 1977-06-06
DK135683C (es) 1977-11-14
ES437009A1 (es) 1977-04-01
ES429949A1 (es) 1976-10-01
SU609465A3 (ru) 1978-05-30
NO140858B (no) 1979-08-20
ES437007A1 (es) 1977-04-01
ES437013A1 (es) 1977-04-01
SE7411382L (es) 1975-03-13
PH10643A (en) 1977-07-22
BE819773A (fr) 1975-03-11
NL7411685A (nl) 1975-03-14
FI58638B (fi) 1980-11-28
FR2242984B1 (es) 1977-11-04
CU21022L (en) 1981-09-09
DE2443682C2 (de) 1983-11-10
ES437008A1 (es) 1977-04-01
GB1484481A (en) 1977-09-01
SU577987A3 (ru) 1977-10-25
ES437012A1 (es) 1977-04-01
IE40523L (en) 1975-03-12
GB1484483A (en) 1977-09-01
GB1484482A (en) 1977-09-01
LU70878A1 (es) 1976-08-19
DD122785A5 (es) 1976-11-05
IL45510A (en) 1978-08-31
AT338797B (de) 1977-09-12
ES437011A1 (es) 1977-04-01
PL97757B1 (pl) 1978-03-30

Similar Documents

Publication Publication Date Title
NL154500B (nl) Werkwijze ter bereiding van 2-cyclohexeen-1-on-derivaten en van herbicide preparaten, die deze bevatten.
NL7512095A (nl) Werkwijze ter bereiding van herbicide verbin- dingen en van preparaten, die deze herbicide verbindingen bevatten.
NL7411047A (nl) Werkwijze ter bereiding van nieuwe pyrimidinen en van farmaceutische preparaten, die dergelij- ke pyrimidinen bevatten.
NL7409447A (nl) Werkwijze voor de bereiding van insecticiden.
NL7410363A (nl) Werkwijze voor de bereiding van pseudotrisa- chariden, alsmede antibacteriele preparaten die deze verbindingen als actieve component bevatten en de zo verkregen preparaten.
NL158701B (nl) Werkwijze voor de bereiding van nitroglycerol bevattende mengsels, werkwijze voor de bereiding van farmaceutische preparaten die deze mengsels bevatten en de aldus verkregen gevormde farmaceutische preparaten.
NL159381B (nl) Werkwijze voor de bereiding van tegen ontstekingen werkzame verbindingen en preparaten die ze bevatten, alsmede werkwijze ter bereiding van de werkzame verbindingen.
NL7412420A (nl) Werkwijze voor de bereiding van isopreen.
NL155827B (nl) Werkwijze voor de bereiding van antibacterieel werkzame benzylpyrimidinen, alsmede voor de bereiding van antibacterieel werkzame preparaten, die deze verbindingen bevatten, en de gevormde preparaten.
NL171270C (nl) Werkwijze voor de bereiding van 1,2,3,4,6,7,12,12a-octahydropyrazinoŸ2',1':6,1Ÿ pyridoŸ3,4-bŸindolen en werkwijze voor de bereiding van preparaten die ze bevatten.
NL7508740A (nl) Werkwijze voor de bereiding van de amiden van apo- vincaminezuur en van desoxyvincaminezuur alsmede werkwijze voor de bereiding van preparaten, die deze verbindingen bevatten.
NL7505214A (nl) Werkwijze voor de bereiding van nieuwe biologisch aktieve stoffen, werkwijze voor de bereiding van preparaten en van voermiddelen die deze stoffen bevatten, alsmede gevormde preparaten en voermid- delen verkregen volgens deze werkwijze.
NL7506011A (nl) Werkwijze ter bereiding van nieuwe derivaten van benzodiazepinen en van farmaceutische preparaten, die deze nieuwe derivaten bevatten.
NL7702757A (nl) Werkwijze voor de bereiding van nieuwe 17-spirosultineverbindingen en overeenkomstige gam- ma-hydroxyzuren daarvan, werkwijze voor de bereiding van farmaceutische preparaten die deze stoffen bevat- ten, alsmede farmaceutische preparaten verkregen volgens deze werkwijze.
NL7409144A (nl) Werkwijze voor de bereiding van gamma,delta - - onverzadigde carbonylverbindingen.
NL7414486A (nl) Werkwijze ter bereiding van cefalosporine derivaten, alsmede antibacteriele preparaten die deze verbindingen als actieve component bevat- ten.
NL7709466A (nl) Werkwijze ter bereiding van cefalosporinen, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL7412208A (nl) Werkwijze voor de bereiding van van gesubstitu- eerde gamma-hydroxylactonen afgeleide carbama- ten, alsmede de bereiding van geneeskundige pre- paraten met toepassing daarvan en de zo verkre- gen preparaten.
NL7414102A (nl) Werkwijze voor de bereiding van kaas.
NL179279B (nl) Werkwijze voor de bereiding van tereftalonitril.
NL7409805A (nl) Werkwijze ter bereiding van 1,2,3,4-tetrahy- droisochinolinederivaten en farmaceutische pre- paraten die deze verbindingen als actieve com- ponent bevatten.
NL176171C (nl) Werkwijze voor de bereiding van anti-adrenerge verbindingen en voor de bereiding van preparaten die ze bevatten.
NL7410190A (nl) Werkwijze ter bereiding van 11-gesubstitueer- de-11-desoxy-pce en -pgf verbindingen, farma- ceutische preparaten die deze verbindingen als actieve component bevatten, alsmede de zo ver- kregen preparaten.
NL156925B (nl) Werkwijze voor de bereiding van een antibioticum; werkwijze voor de bereiding van farmaceutische preparaten; aldus verkregen, gevormde preparaten.
NL180104C (nl) Werkwijze voor de bereiding van benzylpyrimidinen.

Legal Events

Date Code Title Description
SNR Assignments of patents or rights arising from examined patent applications

Owner name: F. HOFFMANN-LA ROCHE AG

V1 Lapsed because of non-payment of the annual fee
NL80 Information provided on patent owner name for an already discontinued patent

Owner name: HOFFMANN